Dr. Sandra Lord, MD
Claim this profileBenaroya Research Institute
Studies Type 1 Diabetes
Studies Diabetes
6 reported clinical trials
10 drugs studied
Area of expertise
1Type 1 Diabetes
mIAA positive
IA-2A positive
ICA positive
2Diabetes
GAD65A positive
mIAA positive
IA-2A positive
Affiliated Hospitals
Clinical Trials Sandra Lord, MD is currently running
Rituximab + Abatacept
for Type 1 Diabetes
This trial is testing whether a combination of two drugs, rituximab-pvvr followed by abatacept, can better preserve insulin production in people newly diagnosed with Type 1 Diabetes compared to rituximab-pvvr alone. Rituximab-pvvr works by reducing harmful immune cells, while abatacept helps calm the immune system. The goal is to see if this combination can improve insulin production and overall diabetes management.
Recruiting0 awards Phase 220 criteria
JAK Inhibitors
for Type 1 Diabetes
This trial is testing two medications, abrocitinib and ritlecitinib, which aim to reduce immune system activity. The study focuses on people who have been recently diagnosed with Stage 3 Type 1 Diabetes. These medications work by calming the immune system to prevent it from attacking insulin-producing cells in the pancreas.
Recruiting0 awards Phase 213 criteria
More about Sandra Lord, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sandra Lord, MD has experience with
- Ritlecitinib
- Abrocitinib 200 MG Oral Tablet
- Placebo
- Vedolizumab
- Etanercept
- Antithymocyte Globulin
Breakdown of trials Sandra Lord, MD has run
Type 1 Diabetes
Diabetes
Diabetes Mellitus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandra Lord, MD specialize in?
Sandra Lord, MD focuses on Type 1 Diabetes and Diabetes. In particular, much of their work with Type 1 Diabetes has involved mIAA positive patients, or patients who are IA-2A positive.
Is Sandra Lord, MD currently recruiting for clinical trials?
Yes, Sandra Lord, MD is currently recruiting for 3 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Sandra Lord, MD has studied deeply?
Yes, Sandra Lord, MD has studied treatments such as Ritlecitinib, Abrocitinib 200 MG Oral Tablet, Placebo.
What is the best way to schedule an appointment with Sandra Lord, MD?
Apply for one of the trials that Sandra Lord, MD is conducting.
What is the office address of Sandra Lord, MD?
The office of Sandra Lord, MD is located at: Benaroya Research Institute, Seattle, Washington 98101 United States. This is the address for their practice at the Benaroya Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.